| Dr Paola Zoe Lasanta, DC | |
|
Calle Barcelo, Edificio Centro Dorado Suite 201 #9, Barranquitas, PR 00794 | |
| (787) 447-5963 | |
| Not Available |
| Full Name | Dr Paola Zoe Lasanta |
|---|---|
| Gender | Female |
| Speciality | Chiropractor |
| Location | Calle Barcelo, Barranquitas, Puerto Rico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093435596 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 870 (Puerto Rico) | Primary |
| Provider Name | Vive Quiropractica |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1720709538 PECOS PAC ID: 4981062676 Enrollment ID: O20230628002100 |
News Archive
The Centers for Disease Control and Prevention (CDC) recently released its Global Health Strategy 2012-2015, which "outlines how CDC will leverage its core strengths to advance four overarching global health goals: improving the health and well-being of people around the world, improving capabilities for preparing and responding to infectious diseases and emerging health threats, building country public health capacity and maximizing organizational capacity," according to the strategy website.
Significantly decreased blood sugar levels over time - and increased well-being. These are just some of the results of a long-term study at Sahlgrenska Academy of continuous glucose monitoring in persons with type 1 diabetes.
Bacteria in the gut are essential for the development of intestinal tumors in mice, according to research led by investigators from the Icahn School of Medicine at Mount Sinai. Removing the bacteria may play a critical role in reducing cancer risk, the researchers write, in the March issue of the Journal of Experimental Medicine.
DaVita, a division of DaVita HealthCare Partners, Inc. and a leading provider of kidney care services announced that its annual charity bike ride, Tour DaVita, raised $900,000 to support Bridge of Life—DaVita Medical MissionsTM in 2012.
A new Tel Aviv University study addresses the challenges of nanoparticle-based cancer-targeting strategies. It also suggests ways of refocusing the collaborative work of cancer researchers and clinicians to move the field forward from "the bench" to the patients.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paola Zoe Lasanta, DC Calle Barcelo, Edificio Centro Dorado Suite 201 #9, Barranquitas, PR 00794 Ph: (787) 447-5963 | Dr Paola Zoe Lasanta, DC Calle Barcelo, Edificio Centro Dorado Suite 201 #9, Barranquitas, PR 00794 Ph: (787) 447-5963 |
News Archive
The Centers for Disease Control and Prevention (CDC) recently released its Global Health Strategy 2012-2015, which "outlines how CDC will leverage its core strengths to advance four overarching global health goals: improving the health and well-being of people around the world, improving capabilities for preparing and responding to infectious diseases and emerging health threats, building country public health capacity and maximizing organizational capacity," according to the strategy website.
Significantly decreased blood sugar levels over time - and increased well-being. These are just some of the results of a long-term study at Sahlgrenska Academy of continuous glucose monitoring in persons with type 1 diabetes.
Bacteria in the gut are essential for the development of intestinal tumors in mice, according to research led by investigators from the Icahn School of Medicine at Mount Sinai. Removing the bacteria may play a critical role in reducing cancer risk, the researchers write, in the March issue of the Journal of Experimental Medicine.
DaVita, a division of DaVita HealthCare Partners, Inc. and a leading provider of kidney care services announced that its annual charity bike ride, Tour DaVita, raised $900,000 to support Bridge of Life—DaVita Medical MissionsTM in 2012.
A new Tel Aviv University study addresses the challenges of nanoparticle-based cancer-targeting strategies. It also suggests ways of refocusing the collaborative work of cancer researchers and clinicians to move the field forward from "the bench" to the patients.
› Verified 4 days ago